Safety Profile Ipamorelin's safety data comes from animal pharmacology studies, the postoperative Phase 2/3 trials, and general clinical experience with the GHRP class
Tufekci, O., Gunes, D., zoul, C., Kolatan, E., Altun, Z., Yilmaz, O., Akta, S., Erbayraktar, Z., Kirkim, G., Mutafolu, K., Soylu, A., erbetiolu, B., Gneri, E
CJC-1295 & Ipamorelin Blend Product Description CJC-1295 is a long-acting GHRH analog that binds to endogenous albumin, significantly prolonging half-life
By the third and fourth week, with consistent administration and the introduction of brief, sensible UV exposure, the effects become more apparent
Thanks to its unique chemical structure, alongside the use of a patented albumin binder fused into the structure, its extended half-life allows for much less frequent dosing